EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Removal of extracellular human amyloid beta aggregates by extracellular proteases in C. elegans

Elisabeth Jongsma, Anita Goyala iD, José Maria Mateos iD, Collin Yvès Ewald iD

eLife · 2023

DOI: 10.7554/elife.83465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Elisabeth Jongsma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Extracellular Matrix Regeneration, Institute of Translational Medicine, Department of Health Sciences and Technology, ETH Zürich, Schwe…. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Alzheimer Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The amyloid beta (Aβ) plaques found in Alzheimer’s disease (AD) patients’ brains contain collagens and are embedded extracellularly. Several collagens have been proposed to influence Aβ aggregate formation, yet their role in clearance is unknown. To investigate the potential role of collagens in forming and clearance of extracellular aggregates in vivo, we created a transgenic Caenorhabditis elegans strain that expresses and secretes human Aβ 1-42 . This secreted Aβ forms aggregates in two distinct places within the extracellular matrix. In a screen for extracellular human Aβ aggregation regulators, we identified different collagens to ameliorate or potentiate Aβ aggregation. We show that a disintegrin and metalloprotease a disintegrin and metalloprotease 2 (ADM-2), an ortholog of ADAM9, reduces the load of extracellular Aβ aggregates. ADM-2 is required and sufficient to remove the extracellular Aβ aggregates. Thus, we provide in vivo evidence of collagens essential for aggregate formation and metalloprotease participating in extracellular Aβ aggregate removal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesAlzheimer DiseaseAnimalsHumansCaenorhabditis elegansPeptide HydrolasesDisintegrinsEndopeptidasesPlaque, AmyloidMetalloproteasesMembrane ProteinsADAM Proteins

Stichwörter der Autor:innen

ADAM9Alzheimer's diseaseC. elegansTIMPaggregationamyloid betacell biologycollagenneuroscience

Substanzen

Amyloid beta-PeptidesPeptide HydrolasesDisintegrinsEndopeptidasesMetalloproteasesADAM9 protein, humanMembrane ProteinsADAM Proteins

Autor:innen und Institutionen

  • Laboratory of Extracellular Matrix Regeneration, Institute of Translational Medicine, Department of Health Sciences and Technology, ETH Zürich, Schwerzenbach, Switzerland.
  • Center for Microscopy and Image Analysis, University of Zurich, Zurich, Switzerland.

ORCID-Profile: Anita Goyala, José Maria Mateos, Collin Yvès Ewald

Förderung

  • NIH HHS
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Jongsma, E., Goyala, A., Mateos, J. M., & Ewald, C. Y. (2023). Removal of extracellular human amyloid beta aggregates by extracellular proteases in C. elegans. eLife. https://doi.org/10.7554/elife.83465

Vancouver

Jongsma E, Goyala A, Mateos JM, Ewald CY. Removal of extracellular human amyloid beta aggregates by extracellular proteases in C. elegans. eLife. 2023. doi:10.7554/elife.83465

BibTeX
@article{Jongsma2023,
  author = {Jongsma, Elisabeth and Goyala, Anita and Mateos, José Maria and Ewald, Collin Yvès},
  title = {Removal of extracellular human amyloid beta aggregates by extracellular proteases in C. elegans},
  journal = {eLife},
  year = {2023},
  doi = {10.7554/elife.83465}
}
Kostenlos starten →